FdaApplication
ANDA 202431
Identifiers
- fda_app_no: ANDA202431
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA USA INC |
| application_type | ANDA |
| approval_date | 2012-05-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NARATRIPTAN | NARATRIPTAN HYDROCHLORIDE | EQ 1MG BASE | TABLET;ORAL |
| NARATRIPTAN | NARATRIPTAN HYDROCHLORIDE | EQ 2.5MG BASE | TABLET;ORAL |
2 products